J. Andreas

发表

Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation

W. Cawello, M. Braun, J. Andreas, 2018, European Journal of Drug Metabolism and Pharmacokinetics.

Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment

W. Cawello, J. Andreas, A. Halabi, 2013, Epilepsia.

Efficacy and safety of the new antiandrogenic oral contraceptive Belara.

J. Andreas, J. Goldberg, J. Goldberg, 1998, Contraception.

Differential effects of human ether-a-go-go-related gene (HERG) blocking agents on QT duration variability in conscious dogs.

J. Schneider, J. Andreas, U. Jahnel, 2005, European journal of pharmacology.

Influence of transdermal rotigotine on ovulation suppression by a combined oral contraceptive.

M. Braun, J. Andreas, Jan-Peer Elshoff, 2009, British journal of clinical pharmacology.

No influence of the CYP2C19‐selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine

W. Cawello, M. Braun, J. Andreas, 2014, Clinical pharmacology in drug development.

Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies.

W. Cawello, M. Braun, J. Andreas, 2012, Clinical therapeutics.

Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara®) and EE/LNG (Microgynon®)

J. Andreas, H. Zahradnik, W. Arp, 2001, Dermatology.

Advances in epilepsy treatment: lacosamide pharmacokinetic profile

W. Cawello, J. Andreas, S. Dimova, 2014, Annals of the New York Academy of Sciences.

An Update on Pharmacological, Pharmacokinetic Properties and Drug–Drug Interactions of Rotigotine Transdermal System in Parkinson’s Disease and Restless Legs Syndrome

W. Cawello, M. Braun, J. Andreas, 2015, Drugs.

Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa

W. Cawello, M. Braun, J. Andreas, 2009, Journal of clinical pharmacology.

A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.

E. Daume, J. Andreas, C. Oberhoff, 1999, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Pharmacokinetics of the antiepileptic drug levetiracetam in healthy Japanese and Caucasian volunteers following intravenous administration

J. Andreas, K. Yamamoto, M. Boyce, 2015, European Journal of Drug Metabolism and Pharmacokinetics.

Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy korean volunteers.

K. Yu, Jung-Ryul Kim, I. Jang, 2015, Clinical therapeutics.

Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine

M. Malik, K. Hnatkova, W. Cawello, 2008, Clinical pharmacology and therapeutics.